Paper · 6975347
T cell growth factor receptors. Quantitation, specificity, and biological relevance.
Robb RJ and 2 others. J Exp Med, 1981. Cited by 1,303 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. T cell growth factor receptors. Quantitation, specificity, and biological relevance. Papers, record 6975347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6975347
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-2 | Major topic |
| Lymphokines | Major topic |
| Animals | |
| Binding Sites | |
| Binding, Competitive | |
| Cattle | |
| Cell Line | |
| Chemical Phenomena | |
| Chemistry | |
| Cytotoxicity, Immunologic | |
| Humans | |
| Isoelectric Focusing | |
| Lymphocyte Activation | |
| Methionine | |
| Mice | |
| Mice, Inbred Strains | |
| Phytohemagglutinins | |
| Rats | |
| Time Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-17323 | NCI NIH HHS | United States | R01CA017323 | PubMed and NIH | NIH RePORTER |
| CA-17643 | NCI NIH HHS | United States | R01CA017643 | PubMed and NIH | NIH RePORTER |
| CA-23108 | NCI NIH HHS | United States | P30CA023108 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,000,675 | Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture. | Immunol Rev | 1980 | https://conductscience.org/library/papers/7000675 | PubMed |
| 2 | 7,000,673 | Interleukin 2: a class of T cell growth factors. | Immunol Rev | 1980 | https://conductscience.org/library/papers/7000673 | PubMed |
| 3 | 6,776,414 | Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. | Nature | 1980 | https://conductscience.org/library/papers/6776414 | PubMed |
| 4 | 6,778,951 | Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. | J Exp Med | 1980 | https://conductscience.org/library/papers/6778951 | PubMed |
| 5 | 7,007,369 | On the mechanism of ligand-induced down-regulation of insulin receptor level in the liver cell. | J Biol Chem | 1981 | https://conductscience.org/library/papers/7007369 | PubMed |
| 6 | 6,451,643 | Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells. | J Immunol | 1981 | https://conductscience.org/library/papers/6451643 | PubMed |
| 7 | 6,260,804 | Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. A direct biochemical and morphologic demonstration. | J Biol Chem | 1981 | https://conductscience.org/library/papers/6260804 | PubMed |
| 8 | 6,971,398 | Functional and molecular characteristics of T-cell growth factor. | Mol Immunol | 1980 | https://conductscience.org/library/papers/6971398 | PubMed |
| 9 | 6,787,609 | Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6787609 | PubMed |
| 10 | 6,169,447 | A permanent human cytotoxic T-cell line with high killing capacity against a lymphoblastoid B-cell line shows preference for HLA A, B target antigens and lacks spontaneous cytotoxic activity. | Cell Immunol | 1981 | https://conductscience.org/library/papers/6169447 | PubMed |
1 to 10 of 41
See all 41 referencesCited by280
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,303 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,510,098 | OX40L and IL-2 combination strategy for gastric cancer immunotherapy. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41510098 | PubMed |
| 41,361,892 | Mutant IL-2-expressing mesenchymal stromal cells promote regulatory T cells proliferation and activation in collagen induced arthritis mice. | Arthritis Res Ther | 2025 | https://conductscience.org/library/papers/41361892 | PubMed |
| 40,680,114 | BLIMP1 negatively regulates IL-2 signaling in T cells. | Sci Adv | 2025 | https://conductscience.org/library/papers/40680114 | PubMed |
| 36,636,297 | Peripheral Blood Mononuclear Cell Cytokine mRNA Profiles in Acute Respiratory Infection Patients. | J Glob Infect Dis | 2022 | https://conductscience.org/library/papers/36636297 | PubMed |
| 35,846,741 | Chicken-Specific Kinome Analysis of Early Host Immune Signaling Pathways in the Cecum of Newly Hatched Chickens Infected With Salmonella enterica Serovar Enteritidis. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35846741 | PubMed |
| 33,523,442 | Regulation of Treg Functions by the Ubiquitin Pathway. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/33523442 | PubMed |
| 31,811,270 | Treg cell-based therapies: challenges and perspectives. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31811270 | PubMed |
| 31,611,250 | Effects of interleukin-2 in immunostimulation and immunosuppression. | J Exp Med | 2020 | https://conductscience.org/library/papers/31611250 | PubMed |
| 30,089,912 | Biology and regulation of IL-2: from molecular mechanisms to human therapy. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/30089912 | PubMed |
| 29,854,806 | Prospects of IL-2 in Cancer Immunotherapy. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29854806 | PubMed |
1 to 10 of 280
See all 280 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3,558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6975347
GET https://conductscience.org/api/papers/v1/6975347/references?page=2